Roche Products Limited

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Patient Information Leaflet last updated on the eMC: 21/12/2010
PIL CellCept 1g/5ml powder for oral suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/12/2010 and displayed until Current
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 10/12/2009 and displayed until 21/12/2010
Reasons for adding or updating:
  • Change to Further Information section
Updated on 04/06/2009 and displayed until 10/12/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 14/11/2008 and displayed until 04/06/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 30/04/2008 and displayed until 14/11/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 10/03/2008 and displayed until 30/04/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 06/11/2007 and displayed until 10/03/2008
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 24/08/2007 and displayed until 06/11/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 22/03/2006 and displayed until 24/08/2007
Reasons for adding or updating:
  • Change to how to administer the medicine
  • Change to Further Information section
  • Change to date of revision
Updated on 23/11/2005 and displayed until 22/03/2006
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 03/11/2005 and displayed until 23/11/2005
Reasons for adding or updating:
  • Change to date of revision
Updated on 19/05/2005 and displayed until 03/11/2005
Reasons for adding or updating:
  • Change of contra-indications
  • Change to information about pregnancy or lactation
Updated on 18/08/2004 and displayed until 19/05/2005
Reasons for adding or updating:
  • Change to side-effects
  • Change to Further Information section
Updated on 27/03/2002 and displayed until 18/08/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   mycophenolate mofetil